Cabazitaxel-d9, CAS 1383572-19-7

Product Description: Cabazitaxel-d9 is deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.

Applications: Cancer-programmed cell death

Formula: C45H48D9NO14

References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Gdowski AS, et al. Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain. Nanomedicine (Lond). 2017 Sep;12(17):2083-2095./[3]Tai X, et al. Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity. J Drug Target. 2016 Sep 9:1-29.

CAS Number: 1383572-19-7

Molecular Weight: 844.99

Compound Purity: 99.4

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic;warming)

Target: Autophagy;Isotope-Labeled Compounds;Microtubule/Tubulin

• SKU: MEXHY-15459S1-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-15459S1-5
• Package Unit: 5 mg
• Quantity Unit: STK